Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability

References

• BanTAPharmacotherapy of mental illness – a historical analysisProg Neuropsychopharmacol Biol Psychiatry20012570972711383974
   PubMed Web of Science ®Google Scholar
• BanTA history of the Collegium Internationale Neuro-Psychopharmacologicum (1957–2004)Prog Neuropsychopharmacol Biol Psychiatry20063059961616564121
   PubMed Web of Science ®Google Scholar
• HimwichHEPsychopharmacologic drugsScience1958127597213495479
   PubMed Web of Science ®Google Scholar
• DawsLCUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyPharmacol Ther2009121899919022290
   PubMed Web of Science ®Google Scholar
• WongDTPerryKWBymasterFPCase history: the discovery of fluoxetine hydrochloride (Prozac)Nat Rev Drug Discov2005476477416121130
   PubMed Web of Science ®Google Scholar
• AndersonIMMeta-analytical studies on new antidepressantsBr Med Bull20015716117811719915
   PubMed Web of Science ®Google Scholar
• CiprianiABrambillaPFurukawaTFluoxetine versus other types of pharmacotherapy for depressionCochrane Database Syst Rev2005CD00418516235353
   PubMed Web of Science ®Google Scholar
• HarrisonGNew or old antidepressants? New is betterBMJ1994309128012817888853
   PubMed Web of Science ®Google Scholar
• WardenDRushAJWisniewskiSRWhat predicts attrition in second step medication treatments for depression?: a STAR*D ReportInt J Neuropsychopharmacol20091245947318611293
   PubMed Web of Science ®Google Scholar
• PapakostasGCharlesDFavaMAre typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorderWorld J Biol Psychiatry20071817853264
   PubMedGoogle Scholar
• NakagawaAWatanabeNOmoriIMEfficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants: a systematic review and meta-analysisCNS Drugs20082258760218547127
   PubMed Web of Science ®Google Scholar
• WatanabeNOmoriIMNakagawaAMirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysisJ Clin Psychiatry2008691404141519193341
   PubMed Web of Science ®Google Scholar
• RooseSPGlassmanAHWalshBTWoodringSTricyclic non-responders: phenomenology and treatmentAm J Psychiatry19861433453483953869
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWHarrisonWQuitkinFMTreatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressantPsychopharmacol Bull1987231691723602314
   PubMedGoogle Scholar
• KirschIDeaconBHuedo-MedinaTScoboriaAMooreTJohnsonBInitial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug AdministrationPLoS Med20085e4518303940
   PubMed Web of Science ®Google Scholar
• BrunoniARLopesMKaptchukTFregniFPlacebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysisPLoS ONE20094e482419293925
   PubMed Web of Science ®Google Scholar
• GelenbergAJThaseMEMeyerREThe history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesJ Clin Psychiatry2008691513152819192434
   PubMed Web of Science ®Google Scholar
• WalshBTSeidmanSNSyskoRGouldMPlacebo response in studies of major depression: variable, substantial, and growingJAMA20022871840184711939870
   PubMed Web of Science ®Google Scholar
• RiefWNestoriucYWeissSWelzelEBarskyAJHofmannSGMeta-analysis of the placebo response in antidepressant trialsJ Affect Disord20091181819246102
   PubMed Web of Science ®Google Scholar
• SneedJRRutherfordBRRindskopfDLaneDTSackeimHARooseSPDesign makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionAm J Geriatr Psychiatry200816657317998306
   PubMed Web of Science ®Google Scholar
• GaynesBNRushAJTrivediMHWisniewskiSRSpencerDFavaMThe STAR*D study: treating depression in the real worldCleve Clin J Med200875576618236731
   PubMed Web of Science ®Google Scholar
• GlezerAByattNCookRJrRothschildAJPolypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinicJ Affect Disord2009117182319103462
   PubMed Web of Science ®Google Scholar
• PandurangiAKDalkilicAPolypharmacy with second-generation antipsychotics: a review of evidenceJ Psychiatr Pract20081434536719057237
   PubMed Web of Science ®Google Scholar
• KennedySHLamRWParikhSVPattenSBRavindranAVCanadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adultsJ Affect Disord2009117S1S219682750
   PubMed Web of Science ®Google Scholar
• RossiniDMagriLLuccaAGiordaniSSmeraldiEZanardiRDoes rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trialJ Clin Psychiatry2005661569157516401159
   PubMed Web of Science ®Google Scholar
• PagninDde QueirozVPiniSCassanoGBEfficacy of ECT in depression: a meta-analytic reviewJ ECT200420132015087991
   PubMed Web of Science ®Google Scholar
• BragaRJPetridesG[Somatic therapies for treatment-resistant psychiatric disorders]Rev Bras Psiquiatr200729Suppl 2S77S8418157436
   PubMed Web of Science ®Google Scholar
• BrunoniARFregniFClinical trial design in noninvasive brain stimulation psychiatric researchInt J Methods Psychiatr Res. In Press.
   Google Scholar
• Repetitive transcranial magnetic stimulation (TMS) for medication-resistant depressionMed Lett Drugs Ther200951111219197234
   PubMed Web of Science ®Google Scholar
• NitscheMAPaulusWExcitability changes induced in the human motor cortex by weak transcranial direct current stimulationJ Physiol2000527 Pt 3:63363910990547
   PubMed Web of Science ®Google Scholar
• NitscheMABoggioPSFregniFPascual-LeoneATreatment of depression with transcranial direct current stimulation (tDCS): a reviewExp Neurol2009219141919348793
   PubMed Web of Science ®Google Scholar
• PrienRFCarpenterLLKupferDJThe definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literatureArch Gen Psychiatry1991487968001929769
   PubMed Web of Science ®Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet200937374675819185342
   PubMed Web of Science ®Google Scholar
• BrunoniARLopesMKaptchukTJFregniFPlacebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysisPLoS ONE20094e482419293925
   PubMed Web of Science ®Google Scholar
• OlveyELSkrepnekGHThe cost-effectiveness of sertraline in the treatment of depressionExpert Opin Pharmacother200892497250818778187
   PubMed Web of Science ®Google Scholar
• FregniFBoggioPSNitscheMAMarcolinMARigonattiSPPascual-LeoneATreatment of major depression with transcranial direct current stimulationBipolar Disord2006820320416542193
   PubMed Web of Science ®Google Scholar
• BoggioPRigonattiSRibeiroRA randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depressionInt J Neuropsychopharmacol20081124925417559710
   PubMed Web of Science ®Google Scholar
• RigonattiSPBoggioPSMyczkowskiMLTranscranial direct stimulation and fluoxetine for the treatment of depressionEur Psychiatry200823747618023968
   PubMed Web of Science ®Google Scholar
• FerrucciRBortolomasiMVergariMTranscranial direct current stimulation in severe, drug-resistant major depressionJ Affect Disord200911821521919286265
   PubMed Web of Science ®Google Scholar
• NelsonJCDelucchiKSchneiderLSEfficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidenceAm J Geriatr Psychiatry20081655856718591576
   PubMed Web of Science ®Google Scholar
• ChenYGuoJJZhanSPatelNCTreatment effects of antidepressants in patients with post-stroke depression: a meta-analysisAnn Pharmacother2006402115212217119102
   PubMed Web of Science ®Google Scholar
• KirschIDeaconBJHuedo-MedinaTBScoboriaAMooreTJJohnsonBTInitial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug AdministrationPlos Med20085e4518303940
   PubMed Web of Science ®Google Scholar
• ArrollBMacgillivraySOgstonSEfficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysisAnn Fam Med2005344945616189062
   PubMed Web of Science ®Google Scholar
• HansenRAGartlehnerGLohrKNGaynesBNCareyTSEfficacy and safety of second-generation antidepressants in the treatment of major depressive disorderAnn Intern Med200514341542616172440
   PubMed Web of Science ®Google Scholar
• MontgomerySABaldwinDSBlierPWhich antidepressants have demonstrated superior efficacy? A review of the evidenceInt Clin Psychopharmacol20072232332917917550
   PubMed Web of Science ®Google Scholar
• PapakostasGIPerlisRHSeifertCFavaMAntidepressant dose reduction and the risk of relapse in major depressive disorderPsychother Psychosom20077626627017700046
   PubMed Web of Science ®Google Scholar
• ChenYPatelNCGuoJJZhanSAntidepressant prophylaxis for poststroke depression: a meta-analysisInt Clin Psychopharmacol20072215916617414742
   PubMed Web of Science ®Google Scholar
• KaymazNvan OsJLoonenAJNolenWAEvidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trialsJ Clin Psychiatry2008691423143619193343
   PubMed Web of Science ®Google Scholar
• HansenRGaynesBThiedaPMeta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressantsPsychiatric Services (Washington, DC)20085911211130
   PubMed Web of Science ®Google Scholar
• McIntyreRSSoczynskaJKKonarskiJZKennedySHThe effect of antidepressants on lipid homeostasis: a cardiac safety concern?Exp Opin Drug Saf20065523537
   PubMed Web of Science ®Google Scholar
• WeissmanAMLevyBTHartzAJPooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infantsAm J Psychiatry20041611066107815169695
   PubMed Web of Science ®Google Scholar
• GartlehnerGThiedaPHansenRAComparative risk for harms of second-generation antidepressants: a systematic review and meta-analysisDrug Saf20083185186518759509
   PubMed Web of Science ®Google Scholar
• GartlehnerGGaynesBNHansenRAComparative benefits and harms of second-generation antidepressants: background paper for the American College of PhysiciansAnn Intern Med200814973475019017592
   PubMed Web of Science ®Google Scholar
• SerrettiAChiesaATreatment-emergent sexual dysfunction related to antidepressants: a meta-analysisJ Clin Psychopharmacol20092925926619440080
   PubMed Web of Science ®Google Scholar
• HammadTALaughrenTPRacoosinJASuicide rates in short-term randomized controlled trials of newer antidepressantsJ Clin Psychopharmacol20062620320716633153
   PubMed Web of Science ®Google Scholar
• MachadoMIskedjianMRuizIAEinarsonTRThe economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analysesPharmacoEconomics20072597999017960955
   PubMed Web of Science ®Google Scholar
• MachadoMLoperaMMDiaz-RojasJJaramilloLEEinarsonTRGroup UNdCPPharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in ColombiaRev Panam Salud Publica20082423323919133171
   PubMed Web of Science ®Google Scholar
• MontgomerySDoyleJJSternLMcBurneyCREconomic considerations in the prescribing of third-generation antidepressantsPharmacoEconomics20052347749115896099
   PubMed Web of Science ®Google Scholar
• Lenox-SmithAConwayPKnightCCost effectiveness of representatives of three classes of antidepressants used in major depression in the UKPharmacoEconomics20042231131915061681
   PubMed Web of Science ®Google Scholar
• CroomKFPloskerGLSpotlight on the pharmacoeconomics of escitalopram in depressionCNS Drugs20041846947315139801
   PubMed Web of Science ®Google Scholar
• SackeimHADillinghamEMPrudicJEffect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effectArch Gen Psychiatry20096672973719581564
   PubMed Web of Science ®Google Scholar
• GreenhalghJKnightCHindDBeverleyCWaltersSClinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studiesHealth Technol Assess200591156iiiiv15774232
   PubMed Web of Science ®Google Scholar
• McLoughlinDMMoggAErantiSThe clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysisHealth Technol Assess20071115417580003
   PubMed Web of Science ®Google Scholar
• LooCKSachdevPMartinDA double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depressionInt J Neuropsychopharmacol2009 [epub ahead of print].
   PubMed Web of Science ®Google Scholar
• SuTPHuangCCWeiIHAdd-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patientsJ Clin Psychiatry20056693093716013911
   PubMed Web of Science ®Google Scholar
• RossiniDLuccaAZanardiRMagriLSmeraldiETranscranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trialPsychiatry Res200513711016225930
   PubMed Web of Science ®Google Scholar
• AveryDHHoltzheimerPE3rdFawazWA controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depressionBiol Psychiatry20065918719416139808
   PubMed Web of Science ®Google Scholar
• FitzgeraldPBBenitezJde CastellaADaskalakisZJBrownTLKulkarniJA randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depressionAm J Psychiatry2006163889416390894
   PubMed Web of Science ®Google Scholar
• Garcia-ToroMSalvaJDaumalJHigh (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depressionPsychiatry Res2006146535716356697
   PubMed Web of Science ®Google Scholar
• AndersonIMDelvaiNAAshimBAdjunctive fast repetitive transcranial magnetic stimulation in depressionBr J Psychiatry200719053353417541116
   PubMed Web of Science ®Google Scholar
• BortolomasiMMinelliAFuggettaGLong-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patientsPsychiatry Res200715018118617303249
   PubMed Web of Science ®Google Scholar
• LooCKMitchellPBMcFarquharTFMalhiGSSachdevPSA sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depressionPsychol Med20073734134917176505
   PubMed Web of Science ®Google Scholar
• MoggAPluckGErantiSVA randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depressionPsychol Med20083832333317935639
   PubMed Web of Science ®Google Scholar
• RumiDOGattazWFRigonattiSPTranscranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled studyBiol Psychiatry20055716216615652875
   PubMed Web of Science ®Google Scholar
• HerwigUFallgatterAJHöppnerJAntidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trialBr J Psychiatry200719144144817978325
   PubMed Web of Science ®Google Scholar
• BretlauLGLundeMLindbergLUndenMDissingSBechPRepetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trialPharmacopsychiatry200841415718311683
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry20061631905191717074942
   PubMed Web of Science ®Google Scholar
• SimpsonKNWelchMJKozelFADemitrackMANahasZCost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysisAdv Ther20092634636819330495
   PubMed Web of Science ®Google Scholar
• KirschIChallenging received wisdom: antidepressants and the placebo effectMcgill J Med20081121922219148327
   PubMedGoogle Scholar
• KirschIMoncrieffJClinical trials and the response rate illusionContemp Clin Trials20072834835117182286
   PubMed Web of Science ®Google Scholar
• PapakostasGIOngurDIosifescuDVMischoulonDFavaMCholesterol in mood and anxiety disorders: review of the literature and new hypothesesEur Neuropsychopharmacol20041413514215013029
   PubMed Web of Science ®Google Scholar
• PayneJLAntidepressant use in the postpartum period: practical considerationsAm J Psychiatry20071641329133217728416
   PubMed Web of Science ®Google Scholar
• DemyttenaereKRisk factors and predictors of compliance in depressionEur Neuropsychopharmacol200313Suppl 3S69S7514550579
   PubMed Web of Science ®Google Scholar
• BolliniPPampallonaSKupelnickBTibaldiGMunizzaCImproving compliance in depression: a systematic review of narrative reviewsJ Clin Pharm Ther20063125326016789991
   PubMed Web of Science ®Google Scholar
• KellerMBHirschfeldRMDemyttenaereKBaldwinDSOptimizing outcomes in depression: focus on antidepressant complianceInt Clin Psychopharmacol200217265267112409679
   PubMed Web of Science ®Google Scholar
• BerlimMTTureckiGDefinition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methodsCan J Psychiatry200752465417444078
   PubMed Web of Science ®Google Scholar
• IvkovicMDamjanovicAJovanovicACveticTJasovic-GasicMLamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerabilityPsychiatr Danub20092118719319556947
   PubMed Web of Science ®Google Scholar
• DebattistaCHawkinsJUtility of atypical antipsychotics in the treatment of resistant unipolar depressionCNS Drugs20092336937719453199
   PubMed Web of Science ®Google Scholar
• Health Care Reform 2009: From the Publishers of the New England Journal of Medicine, 2009. URL: healthcarereform.nejm.org.
   Google Scholar
• RascatiKLDrummondMFAnnemansLDaveyPGEducation in pharmacoeconomics: an international multidisciplinary viewPharmacoEconomics20042213914714871162
   PubMed Web of Science ®Google Scholar
• FregniFBoggioPSNitscheMPascual-LeoneATranscranial direct current stimulationBr J Psychiatry200518644644715863752
   PubMed Web of Science ®Google Scholar
• ManchikantiLBenyaminRMHelmSHirschJAEvidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 3: systematic reviews and meta-analyses of randomized trialsPain Physician200912357219165297
   PubMed Web of Science ®Google Scholar
• LiebeskindDSKidwellCSSayreJWSaverJLEvidence of publication bias in reporting acute stroke clinical trialsNeurology20066797397917000963
   PubMed Web of Science ®Google Scholar
• PapanikolaouKRichardsonCPehlivanidisAPapadopoulou-DaifotiZEfficacy of antidepressants in child and adolescent depression: a meta-analytic studyJ Neural Transm200611339941516075184
   PubMed Web of Science ®Google Scholar
• TurnerEHMatthewsAMLinardatosETellRARosenthalRSelective publication of antidepressant trials and its influence on apparent efficacyN Engl J Med200835825226018199864
   PubMed Web of Science ®Google Scholar
• IoannidisJPTrikalinosTAZintzarasEExtreme between-study homogeneity in meta-analyses could offer useful insightsJ Clin Epidemiol2006591023103216980141
   PubMed Web of Science ®Google Scholar
• SongFLokeYKWalshTGlennyAMEastwoodAJAltmanDGMethodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviewsBMJ2009338b114719346285
   PubMed Web of Science ®Google Scholar
• SongFHarveyILilfordRAdjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventionsJ Clin Epidemiol20086145546318394538
   PubMed Web of Science ®Google Scholar